Figure 7From: Evaluation of efficacy of a new MEK inhibitor, RO4987655, in human tumor xenografts by [18F] FDG-PET imaging combined with proteomic approachesRPPA results. Four markers that showed a significant dose effect on both day 1 and day 3 are visualized showing the individual data points for different animals along with a quadratic fit and the corresponding confidence region.Back to article page